Oculopharyngeal Muscular Dystrophy in Italy

Neuromuscular Disorders - United Kingdom
doi 10.1016/s0960-8966(97)00083-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Oculopharyngeal Muscular Dystrophy

2020English

Guanabenz Treatment Improves Oculopharyngeal Muscular Dystrophy Phenotype

2018English

Functional Impact of an Oculopharyngeal Muscular Dystrophy Mutation in PABPN1

Journal of Physiology
PhysiologySports Science
2017English

hnRNP A1 and a/B Interaction With PABPN1 in Oculopharyngeal Muscular Dystrophy

Canadian Journal of Neurological Sciences
MedicineNeurology
2003English

Autologous Myoblast Transplantation for Oculopharyngeal Muscular Dystrophy: A Phase I/Iia Clinical Study

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Lithium Chloride Attenuates Cell Death in Oculopharyngeal Muscular Dystrophy by Perturbing WNT/Β-Catenin Pathway

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2013English

Cost of Illness Analysis of Duchenne Muscular Dystrophy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Nuclear Entrapment and Extracellular Depletion of PCOLCE Is Associated With Muscle Degeneration in Oculopharyngeal Muscular Dystrophy

BMC Neurology
MedicineNeurology
2013English

Muscular Dystrophy

BMJ
1963English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy